Motor cortical dysfunction develops in spinocerebellar ataxia type 3.
OBJECTIVE
Spinocerebellar ataxia type 3 (SCA3) is an inherited neurodegenerative disorder characterized by cerebellar ataxia and variable expression of clinical features beyond the cerebellum. To gain further insights into disease pathophysiology, the present study explored motor cortex function in SCA3 to determine whether cortical dysfunction was present and if this contributed to the development of clinical manifestations.


METHODS
Clinical phenotyping and longitudinal assessments were combined with central (threshold-tracking transcranial magnetic stimulation) and peripheral (nerve excitability) techniques in 11 genetically characterized SCA3 patients.


RESULTS
Short-interval intracortical inhibition was significantly reduced in presymptomatic and symptomatic SCA3 patients (-1.3±1.4%) compared to healthy controls (10.3±0.7%, P<0.0005), with changes evident prior to clinical onset of ataxia and related to worsening severity (R=-0.78, P<0.005). Central motor conduction time was also significantly prolonged in presymptomatic and symptomatic SCA3 patients (7.5±0.4ms) compared to healthy controls (5.3±0.2ms, P<0.0005) and related to clinical severity (R=0.81, P<0.005). Markers of peripheral motor neurodegeneration and excitability did not correlate with cortical hyperexcitability or ataxia.


CONCLUSIONS
Simultaneous investigation of clinical status, and central and peripheral nerve function has identified progressive cortical dysfunction in SCA3 patients related to the development of ataxia.


CONCLUSIONS
These findings suggest alteration in cortical activity is associated with SCA3 pathogenesis and neurodegeneration.
Discipline of Paediatrics, School of Women's and Children's Health, UNSW Medicine, The University of New South Wales, Sydney, Australia. Electronic address: m.farrar@unsw.edu.au.
Michelle A
MA
Farrar
Department of Neurology, Westmead Hospital and Western Clinical School, University of Sydney, Sydney, Australia.
Steve
S
Vucic
ANZAC Research Institute, University of Sydney, Concord Hospital, New South Wales, Australia.
Garth
G
Nicholson
Sydney Medical School, Brain & Mind Centre, University of Sydney, Sydney, Australia.
Matthew C
MC
Kiernan
D000328:Adult; D005260:Female; D006801:Humans; D008137:Longitudinal Studies; D017827:Machado-Joseph Disease / Q000175:diagnosis* / Q000503:physiopathology* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D009044:Motor Cortex / Q000503:physiopathology*; D050781:Transcranial Magnetic Stimulation / Q000379:methods*
Corticomotoneuron; Spinocerebellar ataxia type 3; Transcranial magnetic stimulation